Loading clinical trials...
Loading clinical trials...
The aim of this trial was to assess glycemic control and incretin release in subjects affected by type-2 diabetes, a condition in which GLP-1 release is impaired. It is known that nutrition affects a ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Antonio Di Mauro
NCT03269058 · Type-2 Diabetes, Oral Antidiabetics
NCT06592950 · Type-2 Diabetes Mellitus (T2DM)
NCT01823510 · Type-2 Diabetes Mellitus, Coronary Artery Disease
NCT01715428 · Type-2 Diabetes
NCT00651105 · Type-2 Diabetes, Healthy
Campus Bio-Medico University of Rome
Rome
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions